Health authorities in New York City have documented the initial occurrence of the more severe Clade I strain of mpox, previously referred to as monkeypox, within the city's limits. This case represents the twelfth instance of Clade I mpox identified across the United States since November 2024.
Patient Details and Travel History
The individual diagnosed with the virus, whose identity remains confidential to protect privacy, is currently undergoing isolation under medical supervision. Officials have verified that this person recently journeyed to Europe before returning to New York City, a metropolis with a population exceeding eight million residents. The specific European destinations visited were not disclosed by authorities, noting that mpox is not endemic in that region.
Global Context and European Warnings
In the previous year, the European Centre for Disease Prevention and Control (ECDC) issued an alert concerning locally acquired cases of Clade Ib mpox in several nations, including Spain, the Netherlands, Italy, and Portugal. These five confirmed cases, involving a newly identified subtype of Clade I, signaled the first indications of community transmission outside the African continent.
While the precise subclade has not been publicly confirmed in the New York City case, the escalating global presence of mpox Clade Ib, particularly in Europe, suggests it might be the causative subclade. However, additional verification is required to establish this definitively.
Understanding Clade I Mpox
Clade I represents the most dangerous iteration of the mpox virus. Endemic to the Congo Basin, this variant historically carries a substantially higher mortality rate and induces more severe illness compared to its Clade II counterpart.
The illness typically manifests five to twenty-one days following exposure, initiating with symptoms such as fever, intense headaches, muscle aches, profound fatigue, and swollen lymph nodes. Subsequently, a distinctive rash develops, often commencing on the face and extending to the palms and soles.
These lesions progress through sequential stages, evolving from flat spots to firm, pus-filled blisters before eventually crusting over. According to the National Institutes of Health (NIH), the fatality rate for Clade I ranges from 1.4 percent to over 10 percent.
Transmission Patterns and Vaccination
In the United States, transmission has predominantly occurred through sexual and intimate contact within social networks involving gay, bisexual, and other men who have sex with men, as well as transgender individuals. However, mpox can infect anyone engaging in close physical contact with an infected person, irrespective of sexual orientation or gender identity.
Primary modes of spread include oral, anal, and vaginal sex, alongside intimate activities like kissing, hugging, cuddling, biting, and massage. Transmission most commonly happens via direct contact with a rash or sores but can also occur through contact with an infected person's mucus or saliva.
Less frequently, it may disseminate through contaminated clothing, bedding, or other items. The virus can also pass from a pregnant person to a fetus or newborn and from animals to humans through bites, scratches, or fluid contact, though this is not a factor in the current US outbreak.
Vaccination plays a crucial role in significantly reducing the risk of contracting mpox and can mitigate symptom severity if infection occurs. For optimal protection, individuals at risk should receive two doses of the JYNNEOS vaccine, with the second dose administered at least twenty-eight days after the first.
Current Mpox Statistics in New York City
Since the global mpox outbreak in 2022, Clade II mpox has continued to circulate in New York City. In 2025, the city reported 398 cases, with 45 cases recorded between January 1 and March 10, 2026, including 16 cases in the past month alone.
In October 2025, the California Department of Public Health reported the first instances of community spread of Clade I mpox in the United States. From the week of January 1, 2026, through March 7, New York City has documented 45 mpox cases, encompassing 16 in the past month.
Public Health Recommendations
City officials emphasize that there is no evidence of community transmission related to this recent Clade I case, and the risk to the general public remains low. Individuals who are male, trans, nonbinary, queer, or gender non-conforming and have sex with men are advised to consult their healthcare providers regarding vaccination.
Additionally, people planning travel to countries where Clade I mpox is spreading and who may engage in sexual activity with new partners while abroad, regardless of sexual orientation or gender identity, should consider obtaining the vaccine. Anyone who perceives themselves at risk for mpox through sexual or intimate contact now or in the future should also evaluate vaccination options.
It remains unclear whether mpox can be transmitted through semen, vaginal fluid, urine, or feces. A person with mpox can transmit the virus from symptom onset until their rash has fully healed and fresh skin has formed. In some instances, individuals may be contagious one to four days before symptoms appear, though the frequency of this occurrence is uncertain. Researchers continue to investigate whether asymptomatic individuals can spread the virus to others.
